Long-Term Results of Nonpenetrating Deep Sclerectomy: Seven Years and 70 Eyes Later
DOI:
https://doi.org/10.48560/rspo.25711Keywords:
Filtering Surgery, Glaucoma, Intraocular Pressure, SclerostomyAbstract
INTRODUCTION: Deep sclerectomy is a nonpenetrating glaucoma surgery that presents as an effective option for open angle glaucoma treatment, with an enhanced safety profile than trabeculectomy. In this study, we present the long-term outcomes of deep sclerectomy in open angle glaucoma patients.
METHODS: Retrospective analysis of patients with open angle glaucoma submitted to nonpenetrating deep sclerectomy (NPDS) between 2011 and 2017, at Hospital Pedro Hispano. A minimum of 2 years of follow-up was required. Absolute success was defined as postoperative intraocular pressure (IOP) ≤18 mmHg without additional treatment and qualified success as post- operative IOP ≤18 mmHg with or without additional treatment.
RESULTS: A total of 76 eyes with primary open angle glaucoma (56 eyes, 73.7%) or pseudo-exfoliative glaucoma (20 eyes, 26.3%) were included in this study. IOP was significantly reduced after surgery (p<0.001), with mean IOP<18 mmHg in all the evaluated follow-up moments (until month 84). Therapeutic success was superior to 90% in in the first 24 months. Absolute success was achieved in 78.4%, 60.7% and 51.2% at 24, 36 and 60 months of follow-up. Qualified success was achieved in 91.6%, 86.9% and 90.2% (24, 36 and 60 months). Additional treatment was re- quired in 33 eyes (43.4%). Postoperatively, the mean number of medications dropped from 2.4 to 0.8 (p<0.05). Postoperative complications were infrequent.
CONCLUSION: Nonpenetrating deep sclerectomy is a safe and effective surgical procedure in open angle glaucoma, allowing sustained IOP control over time, allied to a low rate of surgical complications.
Downloads
References
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901-11. doi: 10.1001/jama.2014.3192.
Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology. 1999;106:2144-53. doi: 10.1016/s0161-6420(99)90497-9.
Roy S, Mermoud A. Deep sclerectomy. Dev Ophthalmol. 2017;59:36-42. doi: 10.1159/000458484
Mansouri K, Shaarawy T. Update on Schlemm’s canal based procedures. Middle East Afr J Ophthalmol. 2015;22:38-44. doi: 10.4103/0974-9233.148347.
Conlon R, Saheb H, Ahmed, II. Glaucoma treatment trends: a review. Can J Ophthalmol. 2017;52:114-24. doi: 10.1016/j. jcjo.2016.07.013.
Cheng JW, Xi GL, Wei RL, Cai JP, Li Y. Efficacy and tolerability of nonpenetrating filtering surgery in the treatment of open-angle glaucoma: a meta-analysis. Ophthalmologica. 2010;224:138-46. doi: 10.1159/000236039.
Chiselita D. Non-penetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgery. Eye. 2001:197-201. doi: 10.1038/eye.2001.60.
Mermoud A, Sickenberg M, Chiou AG, Hediquer SE, Faggio- ni R. Comparison of deep sclerectomy with collagen implant and trabeculectomy in open-angle glaucoma. J Cataract Refract Surg. 1999;25:323-31.
Shaarawy T, Mermoud A. Deep sclerectomy in one eye vs deep sclerectomy with collagen implant in the contralateral eye of the same patient: long-term follow-up. Eye. 2005;19:298-302. doi: 10.1038/sj.eye.6701469.
Cillino S, Di Pace F, Casuccio A, Calvaruso L, Morreale D, Vadalà M, et al. Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial. J Glaucoma. 2004;13:500-6. doi: 10.1097/01. ijg.0000137869.18156.81.
Hodapp E, Anderson DR. Clinical Decisions in Glaucoma. St Louis: CV Mosby Co. 1993.
Bhartiya S, Ichhpujani P, Shaarawy T. Surgery on the Trabecular Meshwork: Histopathological Evidence. J Curr Glaucoma Pract. 2015;9:51-61. doi: 10.5005/jp-journals-10008-1184
Johnson MC, Kamm RD. The role of Schlemm’s canal in aqueous outflow from the human eye. Invest Ophthalmol Vis Sci. 1983;24:320-5.
Varga Z, Shaarawy T. Deep sclerectomy: safety and efficacy. Middle East Afr J Ophthalmol. 2009;16:123-6.
Elbaby A OT, Mousa A, Elridy M, Badawy W, Elbaby M. Deep sclerectomy with porous collagen in open-angle glaucoma, short-term study. J Curr Glaucoma Pract. 2018;12:85-9. doi: 10.5005/jp-journals-10008-1249.
Shibal Bhartiya DD, Tarek Shaarawy. Revisiting Results of Conventional Surgery: Trabeculectomy, Glaucoma Drainage Devices, and Deep Sclerectomy in the Era of MIGS. J Curr Glaucoma Pract. 2019;13:45-9. doi: 10.5005/jp-jour- nals-10078-1248.
El Sayyad F HM, El-Kholify H, Khalil M, El-Maghraby A. Nonpenetrating Deep Sclerectomy versus Trabeculectomy in Bilateral Primary Open angle Glaucoma. Ophthalmology. 2000;107:1671-4.
Guedes R GV. Cirurgia filtrante não penetrante: conceito, téc- nicas e resultados. Arq Bras Oftalmol. 2016;69:605-13.
Bissig A RD, Zaninetti M, Shaarawy T, Mermoud A, Roy S. Ten years follow-up after deep sclerectomy with collagen implant. J Glaucoma. 2008;17:680-6.
Shaarawy T, Karlen M, Schnyder C, Achache F, Sanchez E, Mermoud A. Five-year results of deep sclerectomy with collagen implant. J Cataract Refract Surg. 2001;27:1770-8. doi: 10.1016/s0886-3350(01)01032-x.
Kozobolis V, Kalogianni E, Sideroudi H. Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma. Eur J Ophthalmol. 2020;30:264-8. doi: 10.1177/1120672119827768.
Mercieca K, Steeples L, Anand N, Medscape. Deep sclerectomy for uveitic glaucoma: long-term outcomes. Eye. 2017;31:1008-19. doi: 10.1038/eye.2017.80.
Shaarawy T NC, Schnyder C, et al. Comparative study between deep sclerectomy with and without collagen implant: long term follow up. Br J Ophthalmol. 2004;88:95-8.
Romera-Romero P, Loscos-Arenas J, Moll-Udina A, Roman- ic-Bubalo N, Castellvi-Manent J, Valldeperas X. Two-year Results After Deep Sclerectomy With Nonabsorbable Uveo-scleral Implant (Esnoper-Clip): Surgical Area Analysis Using Anterior Segment Optical Coherence Tomography. J Glaucoma. 2017;26:929-35. doi: 10.1097/IJG.0000000000000756.
Kozobolis VP CE, Tzanakis N, Zacharopoulos I, Pallikaris IG. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma. 2002;11:287-93.
Suominen S, Harju M, Kurvinen L, Vesti E. Deep sclerectomy in normal-tension glaucoma with and without mitomycin-C. Acta Ophthalmol. 2014;92:701-6. doi: 10.1111/aos.12305.
Gianoli F SC, Bovey E, Mermoud A. Combined surgery for cataract and glaucoma: phacoemulsification and deep sclerectomy compared with phacoemulsification and trabeculectomy. J Cataract Refract Surg. 1999;25:340-6.
Bilgin G, Karakurt A, Saricaoglu MS. Combined non-penetrating deep sclerectomy with phacoemulsification versus non-penetrating deep sclerectomy alone. Semin Ophthalmol. 2014;29:146-50. doi: 10.3109/08820538.2013.874466.
Mercieca K, Shevade B, Anand N. Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. Eye. 2015;29:1495-503. doi: 10.1038/ eye.2015.163.
Anand N, Pilling R. Nd:YAG laser goniopuncture after deep sclerectomy: outcomes. Acta Ophthalmol. 2010;88:110-5. doi: 10.1111/j.1755-3768.2008.01494.x.
Anand N, Kumar A, Gupta A. Primary phakic deep sclerectomy augmented with mitomycin C: long-term outcomes. J Glaucoma. 2011;20:21-7. doi: 10.1097/IJG.0b013e3181ccb926.
Bettin P, Di Matteo F, Rabiolo A, Fiori M, Ciampi C, Bandello F. Deep Sclerectomy with mitomycin C and injectable cross-linked hyaluronic acid implant: long-term results. J Glauco- ma. 2016;25:e625-9. doi: 10.1097/IJG.0000000000000309.
Elhofi A, Helaly HA. Outcome of primary nonpenetrating deep sclerectomy in patients with steroid-induced glaucoma. J Ophthalmol. 2018;2018:9215650. doi: 10.1155/2018/9215650.
Klink T, Sauer J, Korber NJ, Grehn F, Much MM, Thederan L, et al. Quality of life following glaucoma surgery: canaloplasty versus trabeculectomy. Clin Ophthalmol. 2015;9:7-16. doi: 10.2147/OPTH.S72357.
Byszewska A, Junemann A, Rekas M. Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment. J Ophthalmol. 2018;2018:2347593. doi: 10.1155/2018/2347593.
European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol. 2021;105:1-169. doi: 10.1136/bjophthalmol-2021-egsguidelines.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Sociedade Portuguesa de Oftalmologia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.
To obtain the Conflict of Interest file (ICMJE template), click here
